San Diego, CA (PRWEB) January 20, 2014
Resource4thePeople announced today that its national network of attorneys will continue to offer free consultations in 2014 to consumers responding to concerns raised by the Food and Drug Administration* involving interior vena cava (IVC) filters marketed by C.R. Bard and other manufacturers.
“We are proud to announce that our policy of providing these consultations to consumers inquiring about the possibility of having suffered health problems identified by the FDA in connection with IVC filters will resume in 2014,” said Resource4thePeople.
The FDA issued the health advisory about IVC filters on Aug. 9, 2010 after agency officials said that they had received numerous reports of adverse events in connection with the device.
The announcement of the continuation of complimentary consultations is being made in response to numerous inquiries from consumers about whether Resource4thePeople's national network of attorneys would, after 2013, continue to offer this service, said Resource4thePeople.
“The continued increase in the number of consumers inquiring about allegations of dangerous side effects from IVC filters demonstrates that there are a great number of affected consumers seeking experienced, aggressive legal help,” said Resource4thePeople.
Resource4thePeople also is announcing that it will continue to provide consumers with updates about the latest developments involving these concerns, including any additional information released by the FDA.
IVC filters are medical devices designed to prevent blood clots in patients at risk for a pulmonary embolism in cases in which an anticoagulant is contraindicated or proven ineffective.
Resource4thePeople is also announcing that in addition to accepting inquiries from consumers about C.R. Bard filters, inquiries about allegations involving other manufacturers also are being reviewed.
The IVCs being added to the list of devices eligible for review by Resource4thePeople attorneys are the Cook Celect, the Cordis OptEase and the ALN IVC filters.
Earlier models identified for review are the C.R. Bard Recovery IVC Filter and G2 IVC Filter, the Braun Tempofilter, the Cook Gunther Tulip and Select and the Rex Medical Option.
Here is a key part of the IVC filters health advisory issued by the FDA:
“Since 2005, the FDA has received 921 device adverse event reports involving IVC filters, of which 328 involved device migration, 146 involved embolizations (detachment of device components), 70 involved perforation of the IVC, and 56 involved filter fracture. Some of these events led to adverse clinical outcomes in patients. These types of events may be related to a retrievable filter remaining in the body for long periods of time, beyond the time when the risk of pulmonary embolism (PE) has subsided.
“The FDA is concerned that these retrievable IVC filters, intended for short-term placement, are not always removed once a patient’s risk for PE subsides. Known long term risks associated with IVC filters include but are not limited to lower limb deep vein thrombosis (DVT), filter fracture, filter migration, filter embolization and IVC perforation.”
Since that warning Resource4thePeople reports that IVC lawsuits have been filed across the country.
Among the latest IVC filter lawsuits was one** filed in U.S. District Court for the Western District of Texas by a woman who had a G2 filter implanted into her inferior vena cava to protect her from contraindications to anticoagulants.
"This is another case in which a consumer is alleging that the Bard IVC filter was defectively designed and simply not strong enough to perform the task for which it was designed," said Resource4thePeople.
"The court file shows that this woman claims that as a result of the injuries she claims to have suffered the woman is asking for a jury trial at which she will seek damages for medical expenses, pain and suffering, mental anguish, physical impairment, disfigurement, economic losses, court costs, and interest."
The Texas woman who recently filed suit claims that the Bard G2 filter failed after it was implanted in her and 2007 and alleges that the filter's arms have penetrated her inferior vena cava walls and cannot be safely removed unless she undergoes major invasive surgery.
Another Texas case*** was filed by another woman who claims a Bard IVC was defectively designed, failed after being implanted in her body and migrated to her heart, according to the court file.
The woman claims that a Bard G2 filter was implanted in her in 2009 to prevent blood clots but failed and caused her to suffer serious health problems and expenses.
She is seeking a jury trial and damages for medical expenses, pain and suffering, mental anguish, physical impairment, disfigurement, economic losses and other expenses, according to the court file.
Another recent filing of a Bard IVC filter lawsuit was made on behalf of a New York woman who is claiming in her lawsuit that the device was defectively designed, broke and caused her to suffer significant internal injuries.****
The woman is alleging the filter was implanted to prevent blood clots but broke apart with particles migrating through her body and damaging her internal organs.
The FDA's health warning* reports that serious health problems can occur on these spider-like devices when the legs that extend from it to block clots break off.
What can then occur, according to the FDA, is that these broken parts from the filter may travel to other parts of the body and cause serious problems such as lower limb deep vein thrombosis (DVT), filter fracture, filter migration, filter embolization and IVC perforation.
**Arnold et al v C.R. Bard, Case #5:13cv00609, US. District Court for the Western District of Texas
*** Case #1:13cv00633 U.S. District Eastern District of Texas, Beaumont Division, Judge Thad Heartfield
****Case # 2:13-cv-2281, U.S. District Court, Eastern District of New York